---
figid: PMC7982470__fphar-12-605803-g001
figtitle: Valine metabolic pathway involved in HIBCH (A), and mechanism of HIBCH deficiency
  with the resulting clinical phenotypes (B)
organisms:
- NA
pmcid: PMC7982470
filename: fphar-12-605803-g001.jpg
figlink: pmc/articles/PMC7982470/figure/F1/
number: F1
caption: Schematic representation of the valine metabolic pathway involved in HIBCH
  (A), and mechanism of HIBCH deficiency with the resulting clinical phenotypes (B).
  SCPCM, S-(2-caboxypropyl)cysteamine; 23DH2MB, 2,3-dihydroxy-2-methylbutyrate.
papertitle: Cinical, Metabolic, and Genetic Analysis and Follow-Up of Eight Patients
  With HIBCH Mutations Presenting With Leigh/Leigh-Like Syndrome.
reftext: Junling Wang, et al. Front Pharmacol. 2021;12:605803.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8864809
figid_alias: PMC7982470__F1
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC7982470__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7982470__fphar-12-605803-g001.html
  '@type': Dataset
  description: Schematic representation of the valine metabolic pathway involved in
    HIBCH (A), and mechanism of HIBCH deficiency with the resulting clinical phenotypes
    (B). SCPCM, S-(2-caboxypropyl)cysteamine; 23DH2MB, 2,3-dihydroxy-2-methylbutyrate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Valine
  - 2-ketoisovaleric
  - isobutyryl
  - acetyl-CoA
  - methylacrylyl-CoA
  - malonate semialdehyde
  - TCA
  - methylaorylyl
  - 3-hydroxyisobutyryl-CoA
  - 3-hydroxypropionate
  - acrylyl
  - 3-hydroxyisobutyryl
  - sarnitine
  - 3-hydroxyisobutyrate
  - 3-hydroxypropionyl-COA
  - succinyl
  - methylmalonate
  - semialdehyde
  - propionyl-CoA
  - methylmalonyl-COA
  - semialdehyde
---
